LINDSAY A LARSON
Allopathic & Osteopathic Physicians|Family Medicine LAKEWOOD, CA NPI 1851618151
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine CA PFIZER INC. All categories
General Payments — all program years on this page
$6,568.27
- Category: General Payments
- Program years: PY2018–2024
- Record count: 331
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,856.09 across 77 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,856.09 | 77 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $246.59 | 11 |
| GENZYME CORPORATION | $235.32 | 4 |
| GlaxoSmithKline, LLC. | $219.74 | 12 |
| Lilly USA, LLC | $109.44 | 6 |
| Astellas Pharma US Inc | $99.67 | 4 |
| Gilead Sciences, Inc. | $83.44 | 3 |
| Sumitomo Pharma America, Inc. | $82.26 | 3 |
| Phathom Pharmaceuticals, Inc. | $81.71 | 3 |
| Novo Nordisk AS | $78.99 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75.29 | 3 |
| Acerta Pharma LLC | $54.59 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $52.52 | 3 |
| SANOFI-AVENTIS U.S. LLC | $49.07 | 2 |
| DEXCOM, INC. | $36.01 | 2 |
| Merck Sharp & Dohme Corporation | $35.15 | 2 |
| Biosense Webster, Inc. | $31.10 | 1 |
| Averitas Pharma Inc. | $30.77 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $30.20 | 1 |
| Kiniksa Pharmaceuticals International, plc | $29.89 | 1 |
| ABBVIE INC. | $29.14 | 1 |
| Amgen Inc. | $27.37 | 1 |
| Otsuka America Pharmaceutical, Inc. | $26.00 | 1 |
| Regeneron Healthcare Solutions, Inc. | $24.90 | 1 |
| Fresenius Kabi USA, LLC | $24.89 | 1 |
| Exact Sciences Corporation | $24.81 | 1 |
| IBSA Pharma Inc. | $22.33 | 1 |
| Seqirus USA Inc | $14.90 | 1 |
By program year
Records — PY2024 (77)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.